{
"Group 1": ["Malignant - can get from synoptic reports", {
    "Invasive ductal carcinoma (IDC)": ["", {
        "IDC: Invasive ductal carcinoma": ["",{}],
    "DCIS: Ductal Carcinoma in Situ": ["",{}],
     "ILC: Invasive Lobular Carcinoma": ["Almost always ER+/PR+/HER2-",{}],
        "Tubular carcinoma": ["",{}],
        "Medullary carcinoma": ["",{}],
        "Mucinous carcinoma": ["",{}],
        "Pagets": ["",{}],
        "Metaplastic carcinoma": ["",{}],
        "NEW LABEL": ["",{}],
        "Apocrine carcinoma": ["",{}],
        "Intraductal Papillary Carcinoma": ["",{}],
        "Intracystic Papillary carcinoma": ["",{}]
        }]

    }],
"Group 2": ["Intermediate risk, still gets excised", {
    "ADH: Atypical Ductal Hyperplasia": ["", {
        "ADH: Atypical Ductal Hyperplasia": ["",{}],
        "Hyperplasia with atypia": ["",{}],
        "Columnar cell change WITH atypia": ["",{}],
        "FEA: Flat epithelial atypia": ["",{}],
        "Intraductal papilloma": ["Slightly less risk of being upgraded to malignant but considered a risk factor so it is excised.",{}],
        "Atypical Phyllodes": ["Excised with wide margins and then followed; underdiagnosed and under-excised, may have demographic/race prevalence",{}],
        "Phyllodes": ["Excised with wide margins and then followed; underdiagnosed and under-excised, may have demographic/race prevalence",{}],
        "Atypical Papilloma": ["",{}]
    }]
}],
"Group 3": ["Overall risk is unclear for these entities; management is driven by the clinician and patient", {
    "Mucocele": ["Some may excise and some may watch",{}],
    "Radial scar": ["Some may excise and some may watch",{}],
    "Microscopic Papilloma": ["",{}],
    "LCIS: Lobular carcinoma in situ": ["Not treated as malignant - more as risk factor",{}]
    }],
"Group 4": ["Do not intervene", {
    "ALH: Atypical lobular hyperplasia": ["",{}],
    "Cyst": ["",{}],
    "Apocrine metaplasia": ["",{}],
    "Biopsy site changes": ["",{}],
    "Columnar cell change WITHOUT atypia": ["",{}],
    "Fat Necrosis": ["",{}],
    "Fibroadenoma": ["",{}],
    "Excisional or Post-surgical change": ["",{}],
    "Fibrosis":["",{}],
    "Fibrocystic disease": ["",{}],
    "Fibroadenomatoid": ["",{}],
    "PASH: Pseudoangiomatous stromal hyperplasia": ["",{}],
    "Sclerosing adenosis": ["",{}],
    "Seroma": ["",{}],
    "UDH: Usual ductal hyperplasia": ["",{}]
    }],
"Others": ["", {
    "Non-Breast Metastasis": ["",{}],
    "Lymphoma": ["",{}],
    "Lymph Node - Benign": ["",{}],
    "Lymph Node - Metastatic": ["",{}],
    "Lactational Change": ["",{}],
    "FNA - Malignant": ["",{}],
    "FNA - Benign": ["",{}],
    "Granular cell tumor": ["",{}],
    "Mesenchymal tumors": ["", {
        "Benign": ["", {
            "Fibromatoses":["",{}],
            "Myofibroblastoma":["",{}],
            "Hamartoma":["",{}],
            "Myxoma":["",{}],
            "Hemangioma":["",{}]
            }],
            "Malignant (sarcomas)": ["",{}]
        }],
    "Uncertain": ["",{}]
    }]
}
